<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1844</number>
    <updateDate>2025-11-19T03:30:01Z</updateDate>
    <updateDateIncludingText>2025-11-19T03:30:01Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2023-06-07</introducedDate>
    <congress>118</congress>
    <legislationUrl>https://www.congress.gov/bill/118th-congress/senate-bill/1844</legislationUrl>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Reported By</name>
            <date>2023-07-26T21:19:40Z</date>
          </item>
          <item>
            <name>Markup By</name>
            <date>2023-06-15T15:52:22Z</date>
          </item>
          <item>
            <name>Referred To</name>
            <date>2023-06-07T16:29:22Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
        <congress>118</congress>
        <number>1418</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-09-20</actionDate>
          <text>Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Innovative FEED Act</title>
        <congress>118</congress>
        <number>1842</number>
        <type>S</type>
        <latestAction>
          <actionDate>2023-06-07</actionDate>
          <text>Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Continuing Appropriations Act, 2024 and Other Extensions Act</title>
        <congress>118</congress>
        <number>5860</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-09-30</actionDate>
          <text>Became Public Law No: 118-15.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Innovative FEED Act of 2023</title>
        <congress>118</congress>
        <number>6687</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-12-08</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2023-07-26</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2023-07-26</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders with an amendment. Without written report.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-07-26</actionDate>
        <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders with an amendment. Without written report.</text>
        <type>Committee</type>
        <actionCode>14000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-06-15</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment favorably.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-06-07</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2023-06-07</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>B001230</bioguideId>
        <fullName>Sen. Baldwin, Tammy [D-WI]</fullName>
        <firstName>Tammy</firstName>
        <lastName>Baldwin</lastName>
        <party>D</party>
        <state>WI</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>M001190</bioguideId>
        <fullName>Sen. Mullin, Markwayne [R-OK]</fullName>
        <firstName>Markwayne</firstName>
        <lastName>Mullin</lastName>
        <party>R</party>
        <state>OK</state>
        <sponsorshipDate>2023-06-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Research and development</name>
          <updateDate>2023-06-16T19:30:33Z</updateDate>
        </item>
        <item>
          <name>User charges and fees</name>
          <updateDate>2023-06-16T19:30:33Z</updateDate>
        </item>
        <item>
          <name>Veterinary medicine and animal diseases</name>
          <updateDate>2023-06-16T19:30:33Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-06-13T20:30:25Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-06-07</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2023-09-27T15:19:34Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Animal Drug and Animal Generic Drug User Fee Amendments of 2023&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements. &lt;/p&gt; &lt;p&gt;The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of &lt;i&gt;major species&lt;/i&gt; (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); and (3) provides statutory authority for the FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria).&lt;/p&gt; &lt;p&gt;Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.&lt;/p&gt;</text>
        </cdata>
      </summary>
      <summary>
        <versionCode>25</versionCode>
        <actionDate>2023-07-26</actionDate>
        <actionDesc>Reported to Senate</actionDesc>
        <updateDate>2024-11-07T19:30:29Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Animal Drug and Animal Generic Drug User Fee Amendments of 2023&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements.&lt;/p&gt;&lt;p&gt;The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of &lt;em&gt;major species&lt;/em&gt; (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); (3) provides statutory authority for the FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria); and (4)&amp;nbsp;provides for the regulation of zootechnical animal food substances as food additives (zootechnical animal food substances&amp;nbsp;are added to the food or drinking water of animals to affect&amp;nbsp;the byproducts of the animal's digestion, reduce foodborne pathogens, or alter the animal's gastrointestinal biome).&lt;/p&gt;&lt;p&gt;Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-07-24T15:21:21Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:39:38Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced for portions of this bill</titleType>
        <titleTypeCode>106</titleTypeCode>
        <title>Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:39:38Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced for portions of this bill</titleType>
        <titleTypeCode>106</titleTypeCode>
        <title>Animal Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:39:38Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to Senate for portions of this bill</titleType>
        <titleTypeCode>108</titleTypeCode>
        <title>Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:38:16Z</updateDate>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Reported to Senate</billTextVersionName>
        <billTextVersionCode>RS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to Senate for portions of this bill</titleType>
        <titleTypeCode>108</titleTypeCode>
        <title>Animal Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:38:16Z</updateDate>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Reported to Senate</billTextVersionName>
        <billTextVersionCode>RS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to Senate</titleType>
        <titleTypeCode>103</titleTypeCode>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:38:16Z</updateDate>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Reported to Senate</billTextVersionName>
        <billTextVersionCode>RS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.</title>
        <updateDate>2023-06-10T03:14:03Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Reported to Senate</type>
        <date>2023-07-26T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118s1844rs/xml/BILLS-118s1844rs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in Senate</type>
        <date>2023-06-07T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118s1844is/xml/BILLS-118s1844is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-07-26</actionDate>
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
